Alpha Galactosidase Market

Global Alpha Galactosidase Market Size, Share & Trends Analysis Report, By Product Type (Capsule, Tablet, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025335 | Category : Pharmaceuticals | Delivery Format: /

The global alpha-galactosidase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The prevalence of flatulence and bloating varies with sex and age. Unhealthy eating habits among the young and working population have led to significantly increased odds for bloating alone and separately for distention. Alpha galactosidase is a topic of interest for clinical research for Fabry disease pharmacological chaperone therapy which is currently under clinical trials. The increasing geriatric population, growing incidence of chronic diseases, and rising healthcare spending are some factors that are expected to accelerate the market growth during the forecast period. Alpha-galactosidase is a digestive enzyme that ruptures the carbohydrates in beans into simpler sugars molecules to make them easier to digest. The most frequently known alpha-galactosidase supplement is referred to by the trade name Beano. 

Beano has been evaluated as safe for use in a healthy adult and elderly population. Beano is not recommended for use in children or infants, nor has it been evaluated for use in pregnant women. These are extensively used in hospital pharmacies, retail pharmacies, and online pharmacies to cure patients. Fabry disease affects a projected 1 in 40,000 to 60,000 males. This disorder also occurs in females; however, the prevalence is unknown. However, it is observed to be accelerated owing to the increasing cases of Fabry disease, which may upsurge the research pace. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Amicus Therapeutics, Inc., Shire plc, Greenovation Biotech GmbH, iBio, Inc., and JCR Pharmaceuticals Co., Ltd., among others. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Alpha Galactosidase Market Report Segmentation

By Product Type

Capsule

Tablet

Others

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Alpha Galactosidase Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific